Diak, Ida-Lina http://orcid.org/0000-0002-9468-5324
Swank, Kimberley
McCartan, Kate
Beganovic, Maya
Kidd, James
Gada, Neha
Kapoor, Rachna
Wolf, Lisa http://orcid.org/0000-0002-7372-6051
Kangas, Laura
Wyeth, Jo
Salvatore, Toni
Fanari, Melina
LeBoeuf, Andrew A.
Mishra, Poonam
Blum, Michael D. http://orcid.org/0000-0003-2306-0914
Dal Pan, Gerald http://orcid.org/0000-0003-4874-5864
Article History
Accepted: 6 November 2022
First Online: 2 December 2022
Declarations
:
: No sources of funding were received for the preparation of this article.
: None of the authors has any conflicts of interest to disclose.
: Ethics approval was not considered necessary for this study because FDA surveillance activity is deemed necessary for the protection of public health.
: Not applicable.
: Not applicable.
: The FAERS data are available via the FAERS Public Dashboard and as Quarterly Data files. Additionally, individual case reports can be requested via a Freedom of Information Act request to the FDA. Additional details can be found here: ExternalRef removed. The FDA-AAPCC NPDS data were obtained under contract with ACMT and AAPCC, respectively.
: Not applicable.
: Conceptualization: ILD, NG, RK, KS, KM, MB, JK, LW, LK, JW, MDB, GDP; data analysis: KS, KM, MB, JK, TS, MF, JW; writing: ILD, NG, KS, KM, MB, JK, TS, JW; review and editing: ILD, KS, KM, MB, JK, NG, RK, LW, ALB, PM, MDB, GDP; approval of the manuscript: all authors.
Free to read: This content has been made available to all.